Xu XX - Search Results

1

Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk.

Yang WL, Godwin AK, Xu XX. Yang WL, et al. Among authors: xu xx. Cancer Res. 2004 Feb 15;64(4):1534-40. doi: 10.1158/0008-5472.can-03-2928. Cancer Res. 2004. PMID: 14973065

2

Focus on epithelial ovarian cancer.

Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X, Hamilton TC. Ozols RF, et al. Cancer Cell. 2004 Jan;5(1):19-24. doi: 10.1016/s1535-6108(04)00002-9. Cancer Cell. 2004. PMID: 14749123 No abstract available.

3

Aberrant epithelial differentiation in ovarian cancer.

Smith ER, Cai KQ, Capo-Chichi CD, Xu X. Smith ER, et al. Cancer Treat Res. 2009;149:147-63. doi: 10.1007/978-0-387-98094-2_7. Cancer Treat Res. 2009. PMID: 19763435 Review. No abstract available.

4

Mammalian target of rapamycin is the key effector of phosphatidylinositol-3-OH-initiated proliferative signals in the thyroid follicular epithelium.

Yeager N, Brewer C, Cai KQ, Xu XX, Di Cristofano A. Yeager N, et al. Among authors: xu xx. Cancer Res. 2008 Jan 15;68(2):444-9. doi: 10.1158/0008-5472.CAN-07-3030. Cancer Res. 2008. PMID: 18199538

5

Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.

Simpkins F, Hevia-Paez P, Sun J, Ullmer W, Gilbert CA, da Silva T, Pedram A, Levin ER, Reis IM, Rabinovich B, Azzam D, Xu XX, Ince TA, Yang JY, Verhaak RG, Lu Y, Mills GB, Slingerland JM. Simpkins F, et al. Among authors: xu xx. Clin Cancer Res. 2012 Nov 1;18(21):5911-23. doi: 10.1158/1078-0432.CCR-12-1257. Epub 2012 Aug 15. Clin Cancer Res. 2012. PMID: 22896656 Free PMC article.

6

Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers.

Capo-Chichi CD, Cai KQ, Xu XX. Capo-Chichi CD, et al. Among authors: xu xx. Biomark Res. 2018 Oct 30;6:30. doi: 10.1186/s40364-018-0144-9. eCollection 2018. Biomark Res. 2018. PMID: 30450209 Free PMC article.

7

Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.

Wang Y, Cai KQ, Smith ER, Yeasky TM, Moore R, Ganjei-Azar P, Klein-Szanto AJ, Godwin AK, Hamilton TC, Xu XX. Wang Y, et al. Among authors: xu xx. Mol Cell Biol. 2016 Aug 26;36(18):2418-30. doi: 10.1128/MCB.00202-16. Print 2016 Sep 15. Mol Cell Biol. 2016. PMID: 27354067 Free PMC article.

8

Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.

Yang WL, Roland IH, Godwin AK, Xu XX. Yang WL, et al. Among authors: xu xx. Oncogene. 2005 Dec 1;24(54):7991-8002. doi: 10.1038/sj.onc.1208943. Oncogene. 2005. PMID: 16044148

9

Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity.

Cai KQ, Wu H, Klein-Szanto AJ, Xu XX. Cai KQ, et al. Among authors: xu xx. Gynecol Oncol. 2009 Jul;114(1):18-25. doi: 10.1016/j.ygyno.2009.03.023. Epub 2009 Apr 16. Gynecol Oncol. 2009. PMID: 19375154 Free PMC article.

10

Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.

Cai KQ, Yang WL, Capo-Chichi CD, Vanderveer L, Wu H, Godwin AK, Xu XX. Cai KQ, et al. Among authors: xu xx. Mol Carcinog. 2007 Feb;46(2):130-43. doi: 10.1002/mc.20273. Mol Carcinog. 2007. PMID: 17131304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results